Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: A fluorescence resonance energy transfer study

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 11, 2000, Pages 966-971

  Chin, Joanna Y ^a   Knowles, Roger B ^b   Schneider, Anja ^c   Drewes, Gerard ^c   Mandelkow, Eva Maria ^c   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DREW UNIVERSITY   (United States)

^c MAX PLANCK UNIT FOR STRUCTURAL MOLECULAR BIOLOGY   (Germany)

Author keywords

Alzheimer disease; Confocal microscopy; Fluorescence resonance energy transfer; MARK; Neurofibrillary tangle; Phosphorylation

Indexed keywords

MICROTUBULE AFFINITY REGULATING KINASE; PHOSPHOTRANSFERASE; PROLINE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENERGY TRANSFER; ENZYME SUBSTRATE; FLUORESCENCE; HUMAN; HUMAN TISSUE; MICROTUBULE; MOLECULAR INTERACTION; NEUROFIBRILLARY TANGLE; PAIRED HELICAL FILAMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0033758105     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.11.966     Document Type: Article

References (35)

1. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer disease
2. Tau protein
3. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau
4. Proline-directed and non-proline-directed phosphorylation of PHF-tau
5. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
6. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
7. Structural stability of paired helical filaments requires microtubule-binding domains of tau: A model for self-association
8. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro
9. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectroscopy
10. Microtubule-associated protein/microtubule affinity regulating kinase (p110MARK)
11. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption
12. Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
13. Levels of tau phosphorylation at different sites in Alzheimer disease brain
14. Hyperphosphorylation of tau in PHF
15. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
16. Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics
17. Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: Implications for MAP kinase activation in Alzheimer's disease
18. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
19. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis
20. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residue 396 and 404
21. Fluorescent excitation transfer immunoassay: A general method for determination of antigens
22. Resonance energy transfer: Methods and applications
23. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
24. Heparin sulfate labeling in neocortex of Alzheimer's disease patients
25. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome
26. Polymerization of tau into filaments in the presence of heparin: The minimal sequence required for tau-tau interaction
27. Glycogen synthase kinase-3 phosphorylation of difference residues in the presence of different factors: Analysis on tau protein
28. Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans-inhibition of microtubule-binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation
29. Rapid assembly of Alzheimer-like paired helical filaments from microtubule associated protein tau monitored by fluorescence in solution
30. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments
31. Glycogen synthase kinase 3 and the Alzheimer-like state of the microtubule-associated protein tau
32. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II
33. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain
34. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
35. Possible role of tau protein kinases in pathogenesis of Alzheimer's disease